샘플 요청 목록

 카트 문의
시장보고서
상품코드
1453730

임상시험 용품 시장(2024-2034년)

Clinical Trial Supplies Market Report 2024-2034
발행일: | 리서치사: Visiongain | 페이지 정보: 영문 373 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 임상시험 용품 시장 규모는 2034년까지 8.8%의 CAGR로 성장할 것으로 예상됩니다.

신흥 시장 성장 기회로 산업 성장 촉진:

임상시험은 중국, 인도, 일본 등 아시아태평양으로 이동하고 있으며, 특히 중국, 한국, 인도 등의 국가에서는 선진국에 비해 비용이 저렴해 환자 모집이 크게 증가하고 있습니다. 개발도상국에서의 초기 단계 임상시험은 비용이 현저하게 저렴해 제약사들에게 매력적인 선택이 되고 있습니다. 예를 들어, 2023년 11월 아스트라제네카는 경쟁이 치열한 KRAS G12D 분야에서 입지를 확보하기 위해 중국 생명공학 기업과 파트너십을 체결하고 계약금으로 2,400만 달러를 지불했습니다. 이번 계약으로 아스트라제네카는 유시노바가 전임상 개발 중인 암 유전자 표적 저분자 억제제 UA022에 대한 전 세계 라이선스를 획득했습니다. 중국 생명공학 기업 우시 앱텍(WuXi AppTec)과 같은 파트너와 협력하여 이 분자의 발견과 개발을 주도적으로 진행했고, 결국 총 3억 9,500만 달러의 마일스톤 지급 가능성을 포함한 아스트라제네카의 제안이 매우 매력적이라고 판단하고 이를 수락하기로 결정했습니다. 또한, Novartis는 2023년 11월 한국의 생명공학 기업 종근당제약과 초기 단계의 HDAC6 억제제에 대한 계약을 체결한 바 있습니다. 계약 조건에 따라 노바티스는 8,000만 달러의 계약금을 지급하고 약 12억 3,000만 달러에 달하는 추가 개발 및 규제 마일스톤을 지급하기로 약속했습니다. 이러한 추세는 임상시험 운영 비용이 낮은 국가로의 전략적 이동을 반영합니다.

세계 임상시험 용품 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추정 및 예측, 각 부문별·지역별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 보고서 개요

제2장 주요 요약

제3장 시장 개요

  • 주요 조사 결과
  • 시장 역학
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
  • COVID-19의 영향 분석
  • Porter's Five Forces 분석
  • PEST 분석

제4장 임상시험 용품 시장 분석 : 로케이션별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 해외 임상 사이트
  • 국내 임상 사이트
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제5장 임상시험 용품 시장 분석 : 유형별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 저분자 제품
  • 바이오로직스
  • 의료기기
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제6장 임상시험 용품 시장 분석 : 서비스별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 제조
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
    • 어세이·테스트 키트
    • IMP·IND
    • 플라세보
    • 기타
  • 포장·라벨링
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
  • 물류·유통
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
    • 콜드체인 유통
    • 비콜드체인 유통
  • 보관·보유
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
  • 콤퍼레이터 조달
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별
  • 기타
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제7장 임상시험 용품 시장 분석 : 치료 분야별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 종양
  • 중추신경계·정신장애
  • 심혈관질환(CVD)
  • 감염증
  • 면역질환
  • 혈액질환
  • 대사장애
  • 소화기질환
  • 기타
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제8장 임상시험 용품 시장 분석 : 단계별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 단계 I
  • 단계 II
  • 단계 III
  • 단계 IV
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제9장 임상시험 용품 시장 분석 : 최종사용자별

  • 주요 조사 결과
  • 시장 매력도 지수
  • 시장 규모 추정과 예측
  • 제약·바이오테크놀러지 기업
  • CRO
  • 의료기기 기업
  • 기타
    • 시장 규모 추정과 예측 : 지역별
    • 시장 점유율 : 지역별

제10장 임상시험 용품 시장 분석 : 지역별

  • 주요 조사 결과
  • 시장 규모 추정과 예측

제11장 북미의 임상시험 용품 시장 분석

제12장 유럽의 임상시험 용품 시장 분석

제13장 아시아의 임상시험 용품 시장 분석

제14장 라틴아메리카의 임상시험 용품 시장 분석

제15장 중동 및 아프리카의 임상시험 용품 시장 분석

제16장 기업 개요

  • 경쟁 상황
  • 전략적 전망
  • Thermo Fisher Scientific Inc.
  • Catalent Inc.
  • IQVIA Holdings Inc
  • Marken
  • Eurofins Scientific SE
  • ICON Plc
  • Parexel International
  • Lonza Group AG
  • Biocair
  • KLIFO
  • Walden Group SAS
  • PCI Pharma Services
  • Sharp Services, LLC
  • Bionical Limited

제17장 결론과 제안

  • Visiongain에 의한 결론
  • 진출 기업에 대한 추천사항
ksm 24.04.16

The global Clinical Trial Supplies market is projected to grow at a CAGR of 8.8% by 2034

The Clinical Trial Supplies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Opportunities in Emerging Markets Projected to Boost Industry Growth

Clinical trials are increasingly moving to developing economies like China, India, and Japan in the Asia Pacific region, with significant growth in patient recruitment in countries such as China, South Korea, and India due to lower costs compared to developed nations. Early phase clinical trials in developing nations are notably cheaper, making them an attractive option for pharmaceutical companies. For instance, in November 2023, AstraZeneca forged a partnership with a Chinese biotechnology company to secure a position in the competitive KRAS G12D field, exchanging $24 million upfront. The agreement grants AstraZeneca a worldwide license to UA022, a small molecule inhibitor targeting the historically challenging oncogene, which was undergoing preclinical development at Usynova. The Chinese biotech, in collaboration with partners such as WuXi AppTec, spearheaded the discovery and advancement of the molecule, ultimately determining that AstraZeneca's offer, which includes potential milestone payments totalling up to $395 million, was highly compelling and thus opted to accept it. Also, in November 2023, Novartis entered into an agreement with Chong Kun Dang Pharmaceutical, a biotechnology company based in Korea, for an early-stage HDAC6 Inhibitor. As per the contract terms, Novartis will provide an initial payment of $80 million and commit to additional development and regulatory milestone payments amounting to nearly $1.23 billion. These trends reflect a strategic shift towards countries offering lower operational expenses for clinical trials.

Challenges Posed by Lack of Comparator Sourcing

The clinical trial supplies market faces significant hurdles due to restrictions imposed by pharmaceutical manufacturers on procuring their products as comparators for clinical trials. These limitations typically encompass quantity constraints, prolonged approval procedures, and additional disclosure requirements, posing challenges for researchers and clinical trial supply chain management. Biologics, in particular, accentuate these difficulties as the lack of internal protocols and procedures from manufacturers exacerbates the situation. For instance, Sharp Clinical Services specializes in offering solutions for clinical trial supply chains, with a focus on comparator sourcing and supply. They cater to pharmaceutical companies conducting clinical trials, aiming to streamline the procurement process. Such firms play a pivotal role in addressing the challenges linked to comparator sourcing, thereby enhancing the efficiency of the clinical trial supply chain. Pharmaceutical manufacturers often impose strict quantity limits on procuring their products for use as comparators in clinical trials. Additionally, obtaining approval for these products can be time-consuming.

What Questions Should You Ask before Buying a Market Research Report?

How is the clinical trial supplies market evolving?

What is driving and restraining the clinical trial supplies market?

How will each clinical trial supplies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each clinical trial supplies submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading clinical trial supplies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the clinical trial supplies projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of clinical trial supplies projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the clinical trial supplies market?

Where is the clinical trial supplies market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trial supplies market today, and over the next 10 years:

Our 373-page report provides 155 tables and 243 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trial supplies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial supplies prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Location

Offshore Clinical Site

Domestic Clinical Site

Type

Small Molecule Products

Biologic Products

Medical Devices

Services

Manufacturing

Assays and Test Kits

IMPs and INDs

Placebos

Others

Packaging and Labelling

Logistics & Distribution

Cold Chain Distribution

Non-cold Chain Distribution

Storage & Retention

Comparator Sourcing

Other CTS Services

Therapeutic Areas

Oncology

CNS and Mental Disorders

Cardiovascular Disease (CVD)

Infectious Disease

Immunology Disease

Blood Disorders

Metabolic Disorders

Digestive Disorders

Other Therapeutic Areas

Phase

Phase I

Phase II

Phase III

Phase IV

End-users

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Medical Device Companies

Other End-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Spain

Italy

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trial Supplies Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Biocair

Bionical Limited

Catalent Inc.

Eurofins Scientific SE

ICON plc

IQVIA Holdings Inc.

KLIFO

Lonza Group AG

Marken

Parexel International

PCI Pharma Services

Sharp Services, LLC

Thermo Fisher Scientific Inc.

Walden Group SAS

Overall world revenue for Clinical Trial Supplies Market, 2024 to 2034 in terms of value the market will surpass US$4,100.0 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trial Supplies Market, 2024 to 2034 report help you?

In summary, our 370+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Clinical Trial Supplies Market, 2024 to 2034, with forecasts for location, type, services, therapeutic areas, phase, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Clinical Trial Supplies Market, 2024 to 2034 market in North America, Europe, Asia Pacific, Latin America, and MEA. Also includes forecast for the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 14 of the major companies involved in the Clinical Trial Supplies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supplies Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Clinical Trial Supplies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growing Decentralisation of Clinical Trials
      • 3.2.1.2 Increasing Number of Clinical Trials
      • 3.2.1.3 Rising Demand for Biologics Propelling Growth of Cold Chain Distribution Supplies
      • 3.2.1.4 Integration of Technical Solutions
      • 3.2.1.5 Increasing Investments in the Development of Novel Pharmaceuticals
      • 3.2.1.6 Technology Advancements are Propelling Market Expansion
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Unavailability of Storage Facilities
      • 3.2.2.2 Lack of Comparator Sourcing
      • 3.2.2.3 High Costs Associated with Drug Developments
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Emerging Economies Expansion and Prioritisation of R&D
      • 3.2.3.2 Increasing Opportunities for Emerging Markets
      • 3.2.3.3 Reduction in Clinical Trials Cost by using Supply Chain is Expected to Propel Market Growth
      • 3.2.3.4 Collaboration and Partnerships among Clinical Trial Supplies Companies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Clinical Trial Supplies Market Analysis by Location

  • 4.1 Key Findings
  • 4.2 Location Segment: Market Attractiveness Index
  • 4.3 Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 4.4 Offshore Clinical Site
    • 4.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Domestic Clinical Site
    • 4.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)

5 Clinical Trial Supplies Market Analysis by Type

  • 5.1 Key Findings
  • 5.2 Type Segment: Market Attractiveness Index
  • 5.3 Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 5.4 Small Molecule Products
    • 5.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Biologic Products
    • 5.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Medical Devices
    • 5.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Clinical Trial Supplies Market Analysis by Services

  • 6.1 Key Findings
  • 6.2 Services Segment: Market Attractiveness Index
  • 6.3 Clinical Trial Supplies Market Size Estimation and Forecast by Services
  • 6.4 Manufacturing
    • 6.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
    • 6.4.3 Assays and Test kits
      • 6.4.3.1 Market Size by Region, 2024-2034 (US$ Million)
      • 6.4.3.2 Market Share by Region, 2024 & 2034 (%)
    • 6.4.4 IMPs and INDs
      • 6.4.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 6.4.4.2 Market Share by Region, 2024 & 2034 (%)
    • 6.4.5 Placebos
      • 6.4.5.1 Market Size by Region, 2024-2034 (US$ Million)
      • 6.4.5.2 Market Share by Region, 2024 & 2034 (%)
    • 6.4.6 Others
      • 6.4.6.1 Market Size by Region, 2024-2034 (US$ Million)
      • 6.4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Packaging and Labelling
    • 6.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Logistics & Distribution
    • 6.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
    • 6.6.3 Cold Chain Distribution
      • 6.6.3.1 Market Size by Region, 2024-2034 (US$ Million)
      • 6.6.3.2 Market Share by Region, 2024 & 2034 (%)
    • 6.6.4 Non-cold Chain Distribution
      • 6.6.4.1 Market Size by Region, 2024-2034 (US$ Million)
      • 6.6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Storage & Retention
    • 6.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)
  • 6.8 Comparator Sourcing
    • 6.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.8.2 Market Share by Region, 2024 & 2034 (%)
  • 6.9 Other CTS Services
    • 6.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 6.9.2 Market Share by Region, 2024 & 2034 (%)

7 Clinical Trial Supplies Market Analysis by Therapeutic Areas

  • 7.1 Key Findings
  • 7.2 Therapeutic Areas Segment: Market Attractiveness Index
  • 7.3 Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 7.4 Oncology
    • 7.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 CNS and Mental Disorders
    • 7.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)
  • 7.6 Cardiovascular Disease (CVD)
    • 7.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.6.2 Market Share by Region, 2024 & 2034 (%)
  • 7.7 Infectious Disease
    • 7.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.7.2 Market Share by Region, 2024 & 2034 (%)
  • 7.8 Immunology Disease
    • 7.8.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.8.2 Market Share by Region, 2024 & 2034 (%)
  • 7.9 Blood Disorders
    • 7.9.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.9.2 Market Share by Region, 2024 & 2034 (%)
  • 7.10 Metabolic Disorders
    • 7.10.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.10.2 Market Share by Region, 2024 & 2034 (%)
  • 7.11 Digestive Disorders
    • 7.11.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.11.2 Market Share by Region, 2024 & 2034 (%)
  • 7.12 Other Therapeutic Areas
    • 7.12.1 Market Size by Region, 2024-2034 (US$ Million)
    • 7.12.2 Market Share by Region, 2024 & 2034 (%)

8 Clinical Trial Supplies Market Analysis by Phase

  • 8.1 Key Findings
  • 8.2 Phases Segment: Market Attractiveness Index
  • 8.3 Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 8.4 Phase I
    • 8.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.4.2 Market Share by Region, 2024 & 2034 (%)
  • 8.5 Phase II
    • 8.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.5.2 Market Share by Region, 2024 & 2034 (%)
  • 8.6 Phase III
    • 8.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.6.2 Market Share by Region, 2024 & 2034 (%)
  • 8.7 Phase IV
    • 8.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 8.7.2 Market Share by Region, 2024 & 2034 (%)

9 Clinical Trial Supplies Market Analysis by End-users

  • 9.1 Key Findings
  • 9.2 End-users Segment: Market Attractiveness Index
  • 9.3 Clinical Trial Supplies Market Size Estimation and Forecast by End-users
  • 9.4 Pharmaceutical and Biotechnology Companies
    • 9.4.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.4.2 Market Share by Region, 2024 & 2034 (%)
  • 9.5 Contract Research Organizations (CROs)
    • 9.5.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.5.2 Market Share by Region, 2024 & 2034 (%)
  • 9.6 Medical Device Companies
    • 9.6.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.6.2 Market Share by Region, 2024 & 2034 (%)
  • 9.7 Other End-users
    • 9.7.1 Market Size by Region, 2024-2034 (US$ Million)
    • 9.7.2 Market Share by Region, 2024 & 2034 (%)

10 Clinical Trial Supplies Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Clinical Trial Supplies Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Clinical Trial Supplies Market Attractiveness Index
  • 11.3 North America Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 North America Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 11.5 North America Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 11.6 North America Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 11.7 North America Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 11.7.1 North America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
    • 11.7.2 North America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
  • 11.8 North America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 11.9 North America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 11.10 North America Clinical Trial Supplies Market Size Estimation and Forecast by End-users
  • 11.11 U.S. Clinical Trial Supplies Market Analysis
  • 11.12 Canada Clinical Trial Supplies Market Analysis

12 Europe Clinical Trial Supplies Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Clinical Trial Supplies Market Attractiveness Index
  • 12.3 Europe Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 12.5 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 12.6 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 12.7 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 12.7.1 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
    • 12.7.2 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
  • 12.8 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 12.9 Europe Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 12.10 Europe Clinical Trial Supplies Market Size Estimation and Forecast by End-users
  • 12.11 Germany Clinical Trial Supplies Market Analysis
  • 12.12 UK Clinical Trial Supplies Market Analysis
  • 12.13 France Clinical Trial Supplies Market Analysis
  • 12.14 Italy Clinical Trial Supplies Market Analysis
  • 12.15 Spain Clinical Trial Supplies Market Analysis
  • 12.16 Russia Clinical Trial Supplies Market Analysis
  • 12.17 Rest of Europe Clinical Trial Supplies Market Analysis

13 Asia Clinical Trial Supplies Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia Clinical Trial Supplies Market Attractiveness Index
  • 13.3 Asia Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 13.4 Asia Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 13.5 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 13.6 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 13.7 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 13.7.1 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
    • 13.7.2 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
  • 13.8 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 13.9 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 13.10 Asia Pacific Clinical Trial Supplies Market Size Estimation and Forecast by End-users
  • 13.11 Japan Clinical Trial Supplies Market Analysis
  • 13.12 China Clinical Trial Supplies Market Analysis
  • 13.13 India Clinical Trial Supplies Market Analysis
  • 13.14 Australia Clinical Trial Supplies Market Analysis
  • 13.15 South Korea Clinical Trial Supplies Market Analysis
  • 13.16 Rest of Asia Clinical Trial Supplies Market Analysis

14 Latin America Clinical Trial Supplies Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Clinical Trial Supplies Market Attractiveness Index
  • 14.3 Latin America Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 14.4 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 14.5 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 14.6 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 14.7 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 14.7.1 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
    • 14.7.2 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
  • 14.8 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 14.9 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 14.10 Latin America Clinical Trial Supplies Market Size Estimation and Forecast by End-users
  • 14.11 Brazil Clinical Trial Supplies Market Analysis
  • 14.12 Mexico Clinical Trial Supplies Market Analysis
  • 14.13 Argentina Clinical Trial Supplies Market Analysis
  • 14.14 Rest of Latin America Clinical Trial Supplies Market Analysis

15 MEA Clinical Trial Supplies Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Clinical Trial Supplies Market Attractiveness Index
  • 15.3 MEA Clinical Trial Supplies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 15.4 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Country
  • 15.5 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Location
  • 15.6 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Type
  • 15.7 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Services
    • 15.7.1 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Manufacturing Services
    • 15.7.2 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Logistics & Distribution Services
  • 15.8 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Therapeutic Areas
  • 15.9 MEA Clinical Trial Supplies Market Size Estimation and Forecast by Phase
  • 15.10 MEA Clinical Trial Supplies Market Size Estimation and Forecast by End-users
  • 15.11 GCC Clinical Trial Supplies Market Analysis
  • 15.12 South Africa Clinical Trial Supplies Market Analysis
  • 15.13 Rest of MEA Clinical Trial Supplies Market Analysis

16 Company Profiles

  • 16.1 Competitive Landscape, 2023
  • 16.2 Strategic Outlook
  • 16.3 Thermo Fisher Scientific Inc.
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2018-2023
      • 16.3.3.2 R&D, 2018-2023
      • 16.3.3.3 Regional Market Shares, 2023
    • 16.3.4 Service Benchmarking
    • 16.3.5 Strategic Outlook
  • 16.4 Catalent Inc.
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2018-2023
      • 16.4.3.2 Regional Market Shares, 2023
    • 16.4.4 Service Benchmarking
    • 16.4.5 Strategic Outlook
  • 16.5 IQVIA Holdings Inc
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Financial Analysis
      • 16.5.3.1 Net Revenue, 2018-2023
      • 16.5.3.2 Regional Market Shares, 2023
    • 16.5.4 Service Benchmarking
    • 16.5.5 Strategic Outlook
  • 16.6 Marken
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Service Benchmarking
    • 16.6.4 Strategic Outlook
  • 16.7 Eurofins Scientific SE
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2018-2023
      • 16.7.3.2 Regional Market Shares, 2023
    • 16.7.4 Service Benchmarking
    • 16.7.5 Strategic Outlook
  • 16.8 ICON Plc
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Financial Analysis
      • 16.8.3.1 Net Revenue, 2017-2022
      • 16.8.3.2 Regional Market Shares, 2023
    • 16.8.4 Service Benchmarking
    • 16.8.5 Strategic Outlook
  • 16.9 Parexel International
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Service Benchmarking
    • 16.9.4 Strategic Outlook
  • 16.10 Lonza Group AG
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Financial Analysis
      • 16.10.3.1 Net Revenue, 2018-2023
      • 16.10.3.2 Regional Market Shares, 2023
    • 16.10.4 Service Benchmarking
    • 16.10.5 Strategic Outlook
  • 16.11 Biocair
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Service Benchmarking
    • 16.11.4 Strategic Outlook
  • 16.12 KLIFO
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Financial Analysis
      • 16.12.3.1 Net Revenue, 2018-2023
    • 16.12.4 Service Benchmarking
    • 16.12.5 Strategic Outlook
  • 16.13 Walden Group SAS
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Service Benchmarking
    • 16.13.4 Strategic Outlook
  • 16.14 PCI Pharma Services
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Service Benchmarking
  • 16.15 Sharp Services, LLC
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Financial Analysis
      • 16.15.3.1 Net Revenue, 2017-2022
      • 16.15.3.2 Regional Market Shares, 2023
    • 16.15.4 Service Benchmarking
    • 16.15.5 Strategic Outlook
  • 16.16 Bionical Limited
    • 16.16.1 Company Snapshot
    • 16.16.2 Company Overview
    • 16.16.3 Service Benchmarking

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from Visiongain
  • 17.2 Recommendations for Market Players
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제